Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Smallpox”

88 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 88 results

Early research (Phase 1)Study completedNCT00053742
What this trial is testing

Phase I/II Trial of Modified Vaccinia Virus Ankara (MVA) Vaccine Against Smallpox

Who this might be right for
Healthy
National Institute of Allergy and Infectious Diseases (NIAID) 80
Post-approval studies (Phase 4)Study completedNCT04392739
What this trial is testing

Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG

Who this might be right for
Smallpox
SIGA Technologies 34
Not applicableStudy completedNCT00928577
What this trial is testing

Safety Surveillance Cohort Study of Vaccinia Vaccine (ACAM2000®)

Who this might be right for
Smallpox
Emergent BioSolutions 14,108
Testing effectiveness (Phase 2)Study completedNCT05995275
What this trial is testing

Investigate The Safety, Tolerability, And Immune Response of a Range of Doses of mRNA-1769 Compared With Placebo in Healthy Participants From ≥18 Years of Age to <50 Years of Age

Who this might be right for
SmallpoxMpox
ModernaTX, Inc. 351
Not applicableStudy completedNCT00123396
What this trial is testing

VHA Clinicians and Bioterror Events: Interactive Web-based Learning

Who this might be right for
SmallpoxAnthrax
US Department of Veterans Affairs 15
Testing effectiveness (Phase 2)Study completedNCT00316589
What this trial is testing

Safety and Immunogenicity of IMVAMUNE® (MVA-BN®) Smallpox Vaccine in HIV Infected Patients

Who this might be right for
HIV Infections
Bavarian Nordic 581
Testing effectiveness (Phase 2)Looking for participantsNCT07379580
What this trial is testing

Clinical Trial Investigating the Safety, Reactogenicity, and Immunogenicity After Immunization With an mRNA-based Mpox Vaccine Candidate in Africa

Who this might be right for
Mpox (Monkeypox)SmallpoxOrthopoxvirus Infection
BioNTech SE 310
Early research (Phase 1)Study completedNCT00079820
What this trial is testing

Safety, Tolerability, and Immune Response of ACAM3000 Modified Vaccinia Ankara (MVA) Smallpox Vaccine in Adults

Who this might be right for
Smallpox
Sanofi Pasteur, a Sanofi Company 110
Testing effectiveness (Phase 2)Study completedNCT00907803
What this trial is testing

Safety, Tolerability, Pharmacokinetics (PK) of the Anti-Orthopox Drug, ST-246

Who this might be right for
Orthopoxviral Disease
SIGA Technologies 107
Not applicableAvailableNCT02080767
What this trial is testing

Tecovirimat (ST-246) Treatment for Orthopox Virus Exposure

Who this might be right for
SmallpoxMonkeypox
U.S. Army Medical Research and Development Command
Large-scale testing (Phase 3)Active Not RecruitingNCT06844500
What this trial is testing

Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC

Who this might be right for
NeonateMaternal TransmissionMpox+5 more
Jean-Pierre Van geertruyden 359
Early research (Phase 1)Study completedNCT00189917
What this trial is testing

Safety, Tolerability and Immune Response of IMVAMUNE (MVA-BN)Smallpox Vaccine in Patients With Atopic Disorders

Who this might be right for
Dermatitis, AtopicHay Fever
Bavarian Nordic 60
Testing effectiveness (Phase 2)Study completedNCT00686582
What this trial is testing

An Open-Label Phase II Study to Evaluate Immunogenicity and Safety of a Single IMVAMUNE Booster Vaccination Two Years After the Last IMVAMUNE Vaccination in Former POX-MVA-005 Vaccinees

Who this might be right for
Smallpox
Bavarian Nordic 304
Not applicableStudy completedNCT00325975
What this trial is testing

Immune Responses to Smallpox Vaccination

Who this might be right for
Smallpox Vaccine
National Institute of Allergy and Infectious Diseases (NIAID) 69
Testing effectiveness (Phase 2)Study completedNCT00032708
What this trial is testing

Dryvax Dilution-Prev Vacc Adults

Who this might be right for
Smallpox
National Institute of Allergy and Infectious Diseases (NIAID) 90
Early research (Phase 1)Study completedNCT05976100
What this trial is testing

Study of the Safety, Tolerability, Pharmacokinetics of NIOCH-14 in Volunteers Aged 18-50 Years

Who this might be right for
SmallpoxMonkeypoxCowpox+1 more
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" 90
Early research (Phase 1)WithdrawnNCT00006630
What this trial is testing

Vaccinia Immune Globulin in Treating or Preventing Vaccinal Infection

Who this might be right for
HealthyCommunicable Diseases
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT01158157
What this trial is testing

VA-006 Vaccinia Vaccine (ACAM2000) for the Production of VIGIV

Who this might be right for
Smallpox Vaccine Adverse Reaction
Emergent BioSolutions 25
Early research (Phase 1)Study completedNCT00565929
What this trial is testing

Safety, Reactogenicity and Immunogenicity of MVA in Hematopoietic Stem Cell Transplant (HSCT) Subjects

Who this might be right for
Variola Major (Smallpox)
National Institute of Allergy and Infectious Diseases (NIAID) 24
Not applicableStudy completedNCT03745131
What this trial is testing

Cohort Study of Healthcare Workers Receiving Imvanex®

Who this might be right for
Monkeypox
Public Health England 120
Next Page